The Dietary Approaches to Stop Hypertension (DASH) trial has been shown to reduce blood pressure and plasma total and LDL-cholesterol (C) compared to a Western diet, but shows no benefit on other blood lipid variables associated with cardiovascular disease (CVD) risk, namely HDL-cholesterol and triglycerides. The overall objective of this study is to determine whether modification of the DASH diet by substituting carbohydrate with fat will result in improvements in multiple biomarkers of CVD risk. Specifically, the investigators will test the hypotheses that modification of the DASH diet by reducing carbohydrate, primarily in the form of simple sugars and glycemic starches, and allowing for a more liberal intake of total and saturated fat, primarily from dairy foods, will: (1) improve lipoprotein markers of CVD risk (reduced total/HDL-C ratio, apolipoprotein B, small LDL particles, and increased HDL-C, apoAI, and large HDL particles); and (2) result in comparable reductions of systolic and diastolic blood pressure to those achieved with the standard DASH diet. The investigators will also assess the effects of the modified DASH diet on markers of insulin resistance and inflammation. Our main hypotheses will be tested by a controlled dietary intervention conducted in 40 healthy men and women who will be randomly allocated to consume, for 3 weeks each, a control Western diet, a standard DASH diet, and a modified low-carbohydrate DASH diet, separated by 2-week washout periods.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
36
3 weeks of a typical Western diet pattern. 48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan. 57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan. 42% carbohydrate, 18% protein, 40% fat.
Cholesterol Research Center, Children's Hospital Oakland Research Institute
Berkeley, California, United States
Total:HDL-cholesterol ratio
Time frame: 4 weeks
HDL-cholesterol
Time frame: 4 weeks
Apolipoprotein B
Time frame: 4 weeks
Apolipoprotein AI
Time frame: 4 weeks
Small LDL particles
Time frame: 4 weeks
Large HDL particles
Time frame: 4 weeks
Total:HDL-cholesterol ratio
Time frame: 9 weeks
Total:HDL-cholesterol ratio
Time frame: 14 weeks
HDL-cholesterol
Time frame: 9 weeks
HDL-cholesterol
Time frame: 14 weeks
Apolipoprotein B
Time frame: 9 weeks
Apolipoprotein B
Time frame: 14 weeks
Apolipoprotein AI
Time frame: 9 weeks
Apolipoprotein AI
Time frame: 14 weeks
Small LDL particles
Time frame: 9 weeks
Small LDL particles
Time frame: 14 weeks
Large HDL particles
Time frame: 9 weeks
Large HDL particles
Time frame: 14 weeks
Blood Pressure
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Triglycerides
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Total Cholesterol
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
LDL-Cholesterol
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Lipoprotein Subclasses (HDL, LDL, IDL, VLDL)
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
HOMA-IR
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.